NO20071020L - 4-arylmorfolin-3-on-derivater, fremstilling og terapeutisk anvendelse derav - Google Patents
4-arylmorfolin-3-on-derivater, fremstilling og terapeutisk anvendelse deravInfo
- Publication number
- NO20071020L NO20071020L NO20071020A NO20071020A NO20071020L NO 20071020 L NO20071020 L NO 20071020L NO 20071020 A NO20071020 A NO 20071020A NO 20071020 A NO20071020 A NO 20071020A NO 20071020 L NO20071020 L NO 20071020L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic use
- arylmorpholine
- derivatives
- preparation
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408222A FR2873373B1 (fr) | 2004-07-23 | 2004-07-23 | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
| PCT/FR2005/001852 WO2006021654A1 (fr) | 2004-07-23 | 2005-07-20 | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071020L true NO20071020L (no) | 2007-02-22 |
Family
ID=34951659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071020A NO20071020L (no) | 2004-07-23 | 2007-02-22 | 4-arylmorfolin-3-on-derivater, fremstilling og terapeutisk anvendelse derav |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7521449B2 (es) |
| EP (1) | EP1773823B1 (es) |
| JP (1) | JP4812759B2 (es) |
| KR (1) | KR20070034066A (es) |
| CN (1) | CN101006084B (es) |
| AR (1) | AR050262A1 (es) |
| AU (1) | AU2005276352A1 (es) |
| BR (1) | BRPI0513581A (es) |
| CA (1) | CA2573446A1 (es) |
| CR (1) | CR8843A (es) |
| EA (1) | EA011035B1 (es) |
| EC (1) | ECSP077181A (es) |
| FR (1) | FR2873373B1 (es) |
| GT (1) | GT200500196A (es) |
| HK (1) | HK1107340A1 (es) |
| HN (1) | HN2005000380A (es) |
| IL (1) | IL180484A0 (es) |
| MA (1) | MA28741B1 (es) |
| MX (1) | MX2007000814A (es) |
| MY (1) | MY142757A (es) |
| NO (1) | NO20071020L (es) |
| PA (1) | PA8640101A1 (es) |
| PE (1) | PE20060553A1 (es) |
| SV (1) | SV2006002176A (es) |
| TN (1) | TNSN06438A1 (es) |
| TW (1) | TW200603800A (es) |
| UA (1) | UA86082C2 (es) |
| UY (1) | UY29022A1 (es) |
| WO (1) | WO2006021654A1 (es) |
| ZA (1) | ZA200700603B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2912058A1 (fr) * | 2007-02-07 | 2008-08-08 | Sanofi Aventis Sa | Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles |
| WO2015200594A2 (en) | 2014-06-25 | 2015-12-30 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751654B1 (fr) * | 1996-07-26 | 1998-10-23 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
| HU224225B1 (hu) * | 1995-12-01 | 2005-06-28 | Sankyo Co. Ltd. | Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására |
| GB9601680D0 (en) * | 1996-01-27 | 1996-03-27 | Pfizer Ltd | Therapeutic agents |
| WO1999028307A1 (fr) * | 1997-12-04 | 1999-06-10 | Sankyo Company, Limited | Derives heterocycliques alicycliques acyles |
| JPH11240880A (ja) * | 1997-12-04 | 1999-09-07 | Sankyo Co Ltd | 脂環式アシル化複素環誘導体 |
| GB9812037D0 (en) * | 1998-06-04 | 1998-07-29 | Pfizer Ltd | Piperidones |
| FR2789390B3 (fr) * | 1999-02-10 | 2001-03-09 | Sanofi Sa | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
| FR2791346B3 (fr) * | 1999-03-25 | 2001-04-27 | Sanofi Sa | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
| CA2393672A1 (en) * | 1999-12-17 | 2001-06-21 | Schering Corporation | Selective neurokinin antagonists |
| FR2824828B1 (fr) * | 2001-05-21 | 2005-05-20 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| GB0130261D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Lactams as tachykinin antagonists |
-
2004
- 2004-07-23 FR FR0408222A patent/FR2873373B1/fr active Active
-
2005
- 2005-07-19 UY UY29022A patent/UY29022A1/es unknown
- 2005-07-19 PE PE2005000833A patent/PE20060553A1/es not_active Application Discontinuation
- 2005-07-20 CN CN2005800286192A patent/CN101006084B/zh not_active Expired - Fee Related
- 2005-07-20 BR BRPI0513581-8A patent/BRPI0513581A/pt not_active IP Right Cessation
- 2005-07-20 EA EA200700098A patent/EA011035B1/ru not_active IP Right Cessation
- 2005-07-20 WO PCT/FR2005/001852 patent/WO2006021654A1/fr active Application Filing
- 2005-07-20 AU AU2005276352A patent/AU2005276352A1/en not_active Abandoned
- 2005-07-20 MY MYPI20053337A patent/MY142757A/en unknown
- 2005-07-20 ZA ZA200700603A patent/ZA200700603B/xx unknown
- 2005-07-20 CA CA002573446A patent/CA2573446A1/fr not_active Abandoned
- 2005-07-20 UA UAA200701878A patent/UA86082C2/ru unknown
- 2005-07-20 KR KR1020077001501A patent/KR20070034066A/ko not_active Application Discontinuation
- 2005-07-20 EP EP05790796.6A patent/EP1773823B1/fr active Active
- 2005-07-20 GT GT200500196A patent/GT200500196A/es unknown
- 2005-07-20 MX MX2007000814A patent/MX2007000814A/es active IP Right Grant
- 2005-07-20 JP JP2007521987A patent/JP4812759B2/ja not_active Expired - Fee Related
- 2005-07-21 PA PA20058640101A patent/PA8640101A1/es unknown
- 2005-07-21 AR ARP050103016A patent/AR050262A1/es unknown
- 2005-07-21 HN HN2005000380A patent/HN2005000380A/es unknown
- 2005-07-22 TW TW094124977A patent/TW200603800A/zh unknown
- 2005-07-22 SV SV2005002176A patent/SV2006002176A/es not_active Application Discontinuation
-
2006
- 2006-12-26 TN TNP2006000438A patent/TNSN06438A1/fr unknown
-
2007
- 2007-01-01 IL IL180484A patent/IL180484A0/en unknown
- 2007-01-09 US US11/621,224 patent/US7521449B2/en not_active Expired - Fee Related
- 2007-01-09 CR CR8843A patent/CR8843A/es unknown
- 2007-01-17 MA MA29619A patent/MA28741B1/fr unknown
- 2007-01-17 EC EC2007007181A patent/ECSP077181A/es unknown
- 2007-02-22 NO NO20071020A patent/NO20071020L/no not_active Application Discontinuation
- 2007-11-22 HK HK07112751.7A patent/HK1107340A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20051165L (no) | Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet | |
| NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| NO20100827L (no) | Glukocorticoid-mimetica, fremgangsmater for fremstilling av dem, farmasoytiske blandinger, og anvendelser derav | |
| DE60315677D1 (de) | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs | |
| NO20062357L (no) | Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer | |
| NO20051100L (no) | Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer | |
| NO20074666L (no) | Imidazo(1,2-A)pyridinforbindelser som VEGF-R2-inhibitorer | |
| NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
| NO20045677L (no) | Inhibitorer av JAK- og CDK2-proteinkinaser | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| NO20073926L (no) | Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| NO20066055L (no) | Pyridinderivater | |
| NO20062561L (no) | Kinoliner nyttige for behandling av kardiovaskulaere sykdommer | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
| RS20050432A (en) | Novel aromatic fluoroglycoside derivatives,pharmaceutical products containing said compounds and the use thereof | |
| NO20061766L (no) | 1,1,1-trifluor-4-fenyl-4-metyl-2-(1H-Pyrrolo'2,3-Cl Pyridin-2-ylmetyl)pentan-2-ol derivater og beslektede forbindelser som glukokortikoidligander for behandling av inflammatoriske sykdommer og diabetes | |
| NO20063479L (no) | Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer | |
| MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
| NO20081217L (no) | Nye benzotiazolonderivater | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| NO20082496L (no) | Pyrazinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |